Simplex Trading
ATHE

Simplex Trading’s Alterity Therapeutics ATHE Stock Holding History

Simplex Trading’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4
Closed -$9K – 5777
2016
Q1 		$9K Buy
4
+3
+300% +$100 ﹤0.01% 3543
2015
Q4 		$7K Buy
+1
New +$51 ﹤0.01% 3589
2015
Q3 		– Hold
0
– – – 4568

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Simplex Trading's ATHE Position: Q2 2016 in Review

Simplex Trading sold out of Alterity Therapeutics (ATHE) in Q2 2016, closing a stake of 23 shares.

Simplex Trading first reported a position in ATHE in Q1 2015 and held it in 5 quarters. The position peaked at $26K in Q2 2015. 13 funds tracked by Wall St. Rank hold ATHE as of Q2 2016.

  • Simplex Trading reported no remaining Alterity Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Simplex Trading sold 23 Alterity Therapeutics shares in Q2 2016.
  • Simplex Trading first reported a position in Alterity Therapeutics in Q1 2015 and held it in 5 quarters.
  • Simplex Trading's Alterity Therapeutics position peaked at $26K in Q2 2015.
  • 13 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2016.

Based on Simplex Trading's 13F filing for Q2 2016, filed 18 Jul 2016.